glp 1 drugs for weight loss reviews Understanding Medications: GLP-1 vs. Phentermine Variable weight-loss and cardiovascular benefits
Description
At 12 months, body mass decreased by 4%, WC decreased by 3.2 cm, and BMI decreased by 1.74 kg/m
Demonstration that exendin-4 is an agonist and exendin-(9-39) an antagonist of the receptor
The study authors are independent from the funders, they had full access to all the data (including statistical reports and tables), they are responsible for the integrity of the data and the accuracy of the data analysis, and they accept responsibility to submit for publication
Future therapies would ideally modify CSF secretion to control ICP but also induce weight loss
Email: [email protected]
